Company intelligence / Profile preview

Intrasense

Montpellier, Occitanie, Franceintrasense.fr ↗

Ownership: Private
Employees: ~60
Development stage: Other

Overview

The Myrian® platform by Intrasense has been adopted by over 1,000 healthcare institutions across more than 40 countries. It offers advanced visualization and analysis of multimodal medical images with specialized modules for various clinical needs. The company’s solutions are certified as medical devices in the US, EU, and Asia. Recent funding supports further development of its Liflow® AI-imaging solution.

Therapeutic areas: PulmonologyOncologyOtherRheumatologyCardiovascular
Modalities: DeviceSoftware
Industry: Medical Imaging

Partnerships

GuerbetMilvue (AI algorithm partner)Nurea (vascular image analysis)Gustave Roussy Cancer CenterCHU of Angers

Beyond the preview

Go deeper on Intrasense.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intrasense.

Explore the full profile